Clinical trial
Determinants of Warfarin Metabolism
NCT00162474 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00162474 |
|---|---|
| Title | Determinants of Warfarin Metabolism |
| Official title | Correlation Between Phenotypic Activity of CYP2C9 and Genetic Polymorphism in CYP2C9 and Warfarin Metabolism. |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Warfarin, Phenytoin |
| Enrollment | 600 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2020 |
| Completion | Dec 1, 2020 |
| First posted | Sep 13, 2005 |
| Last update posted | Jun 12, 2018 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: